WASHINGTON — Pfizer Inc., the world's largest drug maker, will pay a record $2.3 billion civil and criminal penalty over unlawful prescription-drug promotions. Announcing the settlement Wednesday, the ...
TRENTON, N.J. — Pfizer Inc. said Tuesday it is ending development of two medicines that had been in final human testing in order to shift funding to other experimental drugs with more potential. The ...
NEW YORK -- Pfizer Inc. said Tuesday it will form two main research units after completing the buyout of Wyeth, focusing on traditional pharmaceuticals and cutting-edge biotechnology drugs. Pfizer ...
NEW YORK -- Pfizer Inc., the world's largest drugmaker, will pay $68 billion for rival Wyeth in a move that will consolidate two of the industry's largest drug developers. The deal comes as Pfizer's ...
PureTech Ventures has appointed former Pfizer Inc. (NYSE: PFE) R&D president John LaMattina as a senior partner, the Boston-based firm announced in a press release this morning. The life sciences ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback